CD8A and cancer: For example, the cobalt-porphyrin-phospholipid (CoPoP) liposome system developed by Lovell et al. demonstrated how liposomes can efficiently sustain the release of CD8+ T cell epitopes, enhancing the cellular immune responses essential for effective cancer vaccines [53].